Dr. Salussolia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Boston Children's Hospital
300 Longwood, Fegan 11
Boston, MA 02115Phone+1 617-355-6388
Education & Training
Boston Children’s Hospital/Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Child Neurology, 2016 - 2019
Stony Brook Medicine/University HospitalResidency, Pediatrics, 2014 - 2016
Stony Brook University Health Sciences Center School of MedicineClass of 2014
Certifications & Licensure
MA State Medical License 2016 - 2025- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
- American Board of Psychiatry and Neurology Clinical Neurophysiology
Publications & Presentations
PubMed
- AKT-mediated phosphorylation of TSC2 controls stimulus- and tissue-specific mTORC1 signaling and organ growth.Yann Cormerais, Samuel C Lapp, Krystle C Kalafut, Madi Y Cissé, Jong Shin
Biorxiv. 2024-09-23 - 1 citationsTiming the clinical onset of epileptic spasms in infantile epileptic spasms syndrome: A tertiary health center's experience.Aristides Hadjinicolaou, Christina Briscoe Abath, Avantika Singh, Stephanie Donatelli, Catherine L Salussolia
Epilepsia. 2024-04-01 - 3 citationsTreatment-Resistant Epilepsy and Tuberous Sclerosis Complex: Treatment, Maintenance, and Future Directions.Avantika Singh, Aristides Hadjinicolaou, Jurriaan M Peters, Catherine L Salussolia
Neuropsychiatric Disease and Treatment. 2023-01-01
Press Mentions
Pushing the Envelope to Treat Drug-resistant EpilepsyNovember 11th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
